Cubist Systematic Strategies’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-21,465
Closed -$1.48M – 4243
2024
Q1
$1.48M Buy
21,465
+16,197
+307% +$1.09M 0.01% 1866
2023
Q4
$328K Sell
5,268
-3,207
-38% -$179K ﹤0.01% 2754
2023
Q3
$476K Sell
8,475
-170,519
-95% -$9.59M ﹤0.01% 2348
2023
Q2
$9.03M Sell
178,994
-28,556
-14% -$1.52M 0.06% 488
2023
Q1
$11.3M Sell
207,550
-4,790
-2% -$280K 0.07% 399
2022
Q4
$13.3M Buy
212,340
+40,453
+24% +$2.68M 0.08% 329
2022
Q3
$12.1M Buy
171,887
+116,110
+208% +$8.01M 0.07% 367
2022
Q2
$3.16M Buy
55,777
+40,362
+262% +$2.21M 0.02% 1410
2022
Q1
$965K Buy
15,415
+8,026
+109% +$433K 0.01% 2052
2021
Q4
$414K Sell
7,389
-17,638
-70% -$1.08M ﹤0.01% 2587
2021
Q3
$1.63M Buy
25,027
+2,579
+11% +$176K 0.02% 1175
2021
Q2
$1.42M Buy
22,448
+16,217
+260% +$957K 0.02% 1327
2021
Q1
$373K Sell
6,231
-61,468
-91% -$3.34M ﹤0.01% 2128
2020
Q4
$3.38M Buy
67,699
+50,799
+301% +$2.39M 0.05% 654
2020
Q3
$863K Sell
16,900
-4,626
-21% -$193K 0.01% 1420
2020
Q2
$756K Sell
21,526
-137
-0.6% -$4.72K 0.01% 1351
2020
Q1
$550K Sell
21,663
-19,037
-47% -$566K 0.01% 1197
2019
Q4
$1.13M Buy
+40,700
New +$971K 0.02% 1080
2019
Q1
– Sell
-1,136
Closed -$17K – 2455
2018
Q4
$17K Buy
+1,136
New +$16.9K ﹤0.01% 1963

Other funds holding AXNX

Cubist Systematic Strategies's AXNX Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 21,465 shares — an estimated $1.48M sold.

Cubist Systematic Strategies first reported a position in AXNX in Q4 2018 and held it in 19 quarters. The position peaked at $13.3M in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 21,465 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $1.48M.
  • Cubist Systematic Strategies first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 19 quarters.
  • Cubist Systematic Strategies's Axonics, Inc. Common Stock position peaked at $13.3M in Q4 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.